Blood–brain barrier dysfunction: the undervalued frontier of hypertension

Vasiliki Katsi(National and Kapodistrian University of Athens), Dimitrios Tousoulis(National and Kapodistrian University of Athens), Fragkiskos Parthenakis(University Hospital of Heraklion), Matthaios Didagelos(Aristotle University of Thessaloniki), Spyridon Maragkoudakis(University Hospital of Heraklion), Costas Tsioufis(National and Kapodistrian University of Athens), Georgios Charalambous(National and Kapodistrian University of Athens), Maria Marketou(University Hospital of Heraklion)
Journal of Human Hypertension
May 18, 2020
10.1038/s41371-020-0352-2
Cited by 55

Related Papers

2018 ESC/ESH Guidelines for the management of arterial hypertension
|European Heart Journal|2018|10.5k
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial
|The Lancet|2018|781
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial
|The Lancet|2017|739
Anatomical variations in the branches of the human aortic arch in 633 angiographies: clinical significance and literature review
|Surgical and Radiologic Anatomy|2008|243
Hypertension and atrial fibrillation
|Journal of Hypertension|2011|199